Substituting HCG with GnRH agonist to trigger final follicular maturation - A retrospective comparison of three different ovarian stimulation protocols

Reproductive BioMedicine Online

Volumn 13, Issue 2, 2006, Pages 198-201

  Orvieto, Raoul ^a,b   Rabinson, Jacob ^a,b   Meltzer, Simion ^a,b   Zohav, Efraim ^a,b   Anteby, Eyal ^a,b   Homburg, Roy ^a,b  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

GnRH agonist; GnRH antagonist; IVF outcome; Pregnancy

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PROGESTERONE; TRIPTORELIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HOSPITAL ADMISSION; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NIDATION; OOCYTE MATURATION; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 33747065541     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60615-3     Document Type: Article

References (14)

1. Aboulghar M, Al-Inany H 2005 Triggering ovulation for IVF. Reproductive BioMedicine Online 10, 142.
2. Balasch J, Tur R, Creus M et al. 1994 Triggering of ovulation by gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecological Endocrinology 8, 7-12.
3. Caglar GS, Asimakopoulos B, Nikolettos N et al. 2005 Recombinant luteinizing hormone in ovarian stimulation. Reproductive BioMedicine Online 10, 774-785.
4. Emperaire JC 2005 Triggering ovulation with LH. Reproductive BioMedicine Online 11, 270.
5. Emperaire JC, Edwards RG 2004 Time to revolutionize the triggering of ovulation. Reproductive BioMedicine Online 9, 480-483.
6. Fauser BC, de Jong D, Olivennes F et al. 2002 Endocrine profiles after triggering of final oocyte maturation with GnRH-agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. Journal Clinical Endocrinology and Metabolism 87, 709-715.
7. Griesinger G, Diedrich K, Devroey P, Kolibianakis M 2005 GnRH-agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Human Reproduction Update 12, 159-168.
8. Humaidan P, Bredkjær HE, Bungum L et al. 2005 GnRH-agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Human Reproduction 20, 1213-1220.
9. Kol S 2004 Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertility and Sterility 81, 1-5.
10. Kolibianakis EM, Schultze-Mosgau A, Schroer A et al. 2005 A lower ongoing pregnancy rate can be expected when GnRH-agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Human Reproduction 20, 2887-2892.
11. Orvieto R 2005 Can we eliminate severe ovarian hyperstimulation syndrome? Human Reproduction 20, 320-322.
12. Orvieto R, Ben-Rafael Z 1998 Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. Human Reproduction 13, 3306-3309.
13. Practice Committee Report of the American Society for Reproductive Medicine 2003 Ovarian hyperstimulation syndrome. Fertility and Sterility 80, 1309-1314.
14. Segal S, Casper RF 1992 Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertility and Sterility 57, 1254-1258.